Skip to content

Efficacy evaluation of a mind-body medicine-based health promotion course for patients with multiple sclerosis - A mixed-methods study with a randomised controlled trial

Efficacy evaluation of a mind-body medicine-based health promotion course for patients with multiple sclerosis - A mixed-methods study with a randomised controlled trial - BERN MS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036453
Enrollment
60
Registered
2025-04-07
Start date
2025-04-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G35

Interventions

Group 1: The BERN (Behaviour, Exercise, Relaxation, Nutrition) mind-body intervention aims to promote general quality of life and to reduce stress. BERN is an eight-week health promotion course in whi

Sponsors

Universität Witten/Herdecke
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Expanded Disability Scale max. 8 Mini-Mental-Status-Test min. 20 Willigness to change German speaking

Exclusion criteria

Exclusion criteria: Expanded Disability Scale more than 8 Mini-Mental-Status-Test 19 or lower No interest in change Non-German speaking

Design outcomes

Primary

MeasureTime frame
Subjective improvement of quality of life The Perceived Stress Scale, the 12-Item Short Form Survey, the Freiburg Mindfulness Inventory and the Social Support Survey are expected to be integrated in the questionnaire. The aim is to include 60 MS patients in the RCT. The inclusion criteria are: MS diagnosis, age of majority, a score of max. 8 on the Expanded Disability Status Scale and a score of min. 20 on the Mini-Mental Status Test. The course is accompanied by a survey with three measurement points. The first data collection (T0) takes place at the beginning of the intervention. The second survey (T1) takes place after completion of the course and the third twelve weeks after the end of the course (T2). The control group completes T0, T1 and T2 and receives the usual medical and therapeutic treatment.

Secondary

MeasureTime frame
Stress reduction

Countries

Germany

Contacts

Public ContactTobias Esch

Universität Witten/Herdecke

igvf@uni-wh.de+49 2302 / 926-847

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026